A Perspective on the Efficacy and Safety of Intensive Antiplatelet Therapy in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38

American Journal of Cardiology

Volumn 101, Issue 9, 2008, Pages 1367-1370

  Wiviott, Stephen D ^a   Braunwald, Eugene ^a   Murphy, Sabina A ^a   Antman, Elliott M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CLOPIDOGREL; METOPROLOL; PRASUGREL; PRAVASTATIN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; FIBRINOLYSIS; HEART INFARCTION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE;

EID: 43049165804     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.016     Document Type: Note

References (16)

1. S.D. Wiviott E.M. Antman C.M. Gibson G. Montalescot J. Riesmeyer G. Weerakkody K.J. Winters J.W. Warmke C.H. McCabe E. Braunwald Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) Am Heart J 152 2006 627 635
2. S.D. Wiviott E. Braunwald C.H. McCabe G. Montalescot W. Ruzyllo S. Gottlieb F.J. Neumann D. Ardissino S. De Servi S.A. Murphy Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
3. V. Serebruany Excess rates of nonfatal myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: preventing clinical events or chasing enzymatic ghosts? Am J Cardiol 000 2008 [Epub ahead of print]
4. J.S. Alpert K. Thygesen E. Antman J.P. Bassand Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction J Am Coll Cardiol 36 2000 959 969
5. K. Thygesen J.S. Alpert H.D. White A.S. Jaffe F.S. Apple M. Galvani H.A. Katus L.K. Newby J. Ravkilde B. Chaitman Universal definition of myocardial infarction Circulation 116 2007 2634 2653
6. E.M. Antman M. Cohen P.J. Bernink C.H. McCabe T. Horacek G. Papuchis B. Mautner R. Corbalan D. Radley E. Braunwald The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842
7. D.L. Bhatt K.A. Fox W. Hacke P.B. Berger H.R. Black W.E. Boden P. Cacoub E.A. Cohen M.A. Creager J.D. Easton Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
8. C.P. Cannon E. Braunwald C.H. McCabe D.J. Rader J.L. Rouleau R. Belder S.V. Joyal K.A. Hill M.A. Pfeffer A.M. Skene Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
9. S.R. Steinhubl P.B. Berger J.T. Mann III E.T. Fry A. DeLago C. Wilmer E.J. Topol Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
10. S. Yusuf F. Zhao S.R. Mehta S. Chrolavicius G. Tognoni K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
11. Z.M. Chen L.X. Jiang Y.P. Chen J.X. Xie H.C. Pan R. Peto R. Collins L.S. Liu Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1607 1621
12. G.W. Stone B.T. McLaurin D.A. Cox M.E. Bertrand A.M. Lincoff J.W. Moses H.D. White S.J. Pocock J.H. Ware F. Feit Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
13. G.W. Stone H.D. White E.M. Ohman M.E. Bertrand A.M. Lincoff B.T. McLaurin D.A. Cox S.J. Pocock J.H. Ware F. Feit Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial Lancet 369 2007 907 919
14. G. Patti G. Colonna V. Pasceri L.L. Pepe A. Montinaro G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) study Circulation 111 2005 2099 2106
15. S.D. Wiviott E. Braunwald E. Antman Prasugrel versus clopidogrel New Engl J Med 358 2008 1299 1300
16. A.M. Lincoff J.A. Bittl R.A. Harrington F. Feit N.S. Kleiman J.D. Jackman I.J. Sarembock D.J. Cohen D. Spriggs R. Ebrahimi Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863